[Pediatric bipolar disorder - case report of a bipolar patient with disease onset in childhood and adolescence: implications for diagnosis and therapy].
In recent years, intense controversies have evolved about the existence and exact diagnostic criteria of pediatric bipolar affective disorder. The present study aims to discuss pediatric bipolar affective disorder based on the current literature focussing on the diagnostic prospects. Based on a case study, a process of bipolar disorder developed in childhood is depicted exemplarily. Because of the high comorbidity and overlapping symptoms of paediatric bipolar affective disorder and other psychiatric disorders, the major impact of the differential diagnosis has to be stressed. An early diagnosis and the treatment possibilities are discussed.
Psychiatrie, Medizinische Universität Graz.
N
N
Lackner
Psychiatrie, Medizinische Universität Graz.
A
A
Birner
Psychiatrie, Medizinische Universität Graz.
S A
SA
Bengesser
Therapiezentrum Justuspark, BVA, Bad Hall.
B
B
Reininghaus
Psychiatrie, Medizinische Universität Graz.
H P
HP
Kapfhammer
Psychiatrie, Medizinische Universität Graz.
E
E
Reininghaus
D000293:Adolescent; D017668:Age of Onset; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy*; D002648:Child; D003937:Diagnosis, Differential; D003987:Dibenzothiazepines / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D008803:Mianserin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000078785:Mirtazapine; D009483:Neuropsychological Tests; D011569:Psychiatric Status Rating Scales; D000069348:Quetiapine Fumarate; D012919:Social Behavior; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D006993:Hypnotics and Sedatives; D008803:Mianserin; D000069348:Quetiapine Fumarate; D000078785:Mirtazapine